Breast cancer is the world’s most prevalent cancer, and the second cause of cancer deaths worldwide, affecting 1 in 8 women in the world. In 40% of cases, mastectomy is the usual treatment followed by chemotherapy or radiotherapy, and only 14% of women receive reconstructive surgery after this procedure.
Although still a relatively young sector, the FemTech industry is certainly having its moment, with women’s health needs being positioned at the forefront of an investment boom..
We’ve all experienced women’s health issues either first or second hand; whether you’ve tested a range of contraceptives before landing on the one with the least side effects, witnessed a friend suffering from the excruciating side effects of endometriosis, or heard about a couple’s frantic attempt to track ovulation in order to conceive.
As we enter the new year, and after indulging way too much over the Christmas period. I thought it would be a great opportunity to sit down and reflect on the last 12 months within my specialist sector of Surgical Robotics. And what a year it has been for the space, from colossal funding rounds to global clearance, and market entry from the goliaths of industry. 2021 has been a huge year for the space and seeing so much traction has been very exciting.
The healthcare industry is being steadily transformed by artificial intelligence (AI) and machine learning. Just as AI is reshaping several industries, so too it is bringing new opportunities, and risks, to the world of MedTech.
CorWave: The heart pump inspired by Marine Animals Last month, RW spoke with Charlotte Rasser,
Ph.D., Strategy & Scientific Affairs Manager at CorWave, an exciting French medtech start-up that
develops innovative cardiac assist devices for heart failure patients.
Last week, myself and Nadia Djema had the pleasure of speaking with one of the talented female leaders making an impact within surgical robotics; Sophie Cahen, CEO and founder of French start-up, Ganymed Robotics.
Earlier this month, RW Search had the pleasure of speaking with Dr. Steven LeBoeuf, President and Co-Founder of Valencell, and leader in transforming the science of wearable biometrics. Steven is a powerhouse in his field, with an extensive background in technology-related sectors.
This month, I had the pleasure of interviewing the CEO of XACT Robotics, Chen Levin as part of our “Leaders in MedTech” series. Chen is a seasoned leader in the healthcare space with vast experience in management and operational positions. Throughout her career, Chen has contributed to and played an instrumental part in Israel’s Biomed industry’s continuous growth.